aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
MediPrint Ophthalmics, founded in 2001 and based in San Diego, California, is a clinical-stage eye care pharmaceutical company. Its core mission is to protect sight through the development and commercialization of a proprietary ocular drug delivery portfolio. The company focuses on innovative solutions for eye care, aiming to address unmet medical needs in ophthalmology.
MediPrint Ophthalmics has made significant strides in the field of ocular drug delivery, leveraging its proprietary technologies to enhance patient outcomes. The company's impact is marked by its commitment to advancing eye care and improving the quality of life for individuals with vision-related conditions.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was MediPrint Ophthalmics founded?
MediPrint Ophthalmics was founded in 2001.
Where is MediPrint Ophthalmics’s headquarters located?
MediPrint Ophthalmics’s headquarters is located in San Diego, CA, US.
When was MediPrint Ophthalmics’s last funding round?
MediPrint Ophthalmics’s most recent funding round was for $2.5M (USD) in March 2022.
How many employees does MediPrint Ophthalmics have?
MediPrint Ophthalmics has 7 employees as of Feb 5, 2024.
How much has MediPrint Ophthalmics raised to-date?
As of July 05, 2023, MediPrint Ophthalmics has raised a total of $7M (USD) since Mar 15, 2022.
Add Comparison
Total Raised to Date
$7M
USD
Last Update Mar 15, 2022
Last Deal Details
$2.5M
USD
Mar 15, 2022
Series A
Total Employees Over Time
7
As of Feb 2024
MediPrint Ophthalmics Address
9899 Hibert Street
suite a
San Diego,
California
92131
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts